Delivering critical life-saving services every day, but with increasing pressures to drive global efficiency and keep local control, the Life Sciences sector needs more control and clarity over its risk profile than ever before. Sigma7 supports efficient risk management processes across cyber and kinetic risk and facilitates investment prioritization across a range of functions and departments.
The Life Sciences sector delivers the humanity-critical life-saving products through pharmaceuticals, biotechnology, medical devices and healthcare services. However, bringing these miracle products to market comes with exhaustive R&D investment, complex supply chains and robust regulatory compliance. Efficient life science risk management processes are essential to ensuring operational continuity and reputational integrity throughout the development, trial and commercialization stages. Sigma7 offers an innovative combined cyber and kinetic risk resiliency capability, helping the most innovative companies avoid disruption.